Broadcrest Asset Management, LLC Bio Techne Corp Transaction History

Broadcrest Asset Management, LLC

$44.4 Million
Q2 2025

A detailed history of Broadcrest Asset Management, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Broadcrest Asset Management, LLC holds 125,000 shares of TECH stock, worth $7.93 Million. This represents 14.48% of its overall portfolio holdings.

Number of Shares

125,000

Previous 150,000 16.67%

Holding current value

$7.93 Million

Previous $8.79 Million 26.87%

% of portfolio

14.48%

Previous 27.95%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$46.66 - $58.38 $1.17 Million - $1.46 Million	-25,000 Reduced 16.67%	125,000 $6.43 Million
Q1 2025 May 09, 2025	BUY	$58.47 - $78.75 $2.92 Million - $3.94 Million	50,000 Added 50.0%	150,000 $8.79 Million
Q4 2024 Feb 11, 2025	SELL	$66.37 - $78.17 $6.64 Million - $7.82 Million	-100,000 Reduced 50.0%	100,000 $7.2 Million
Q3 2024 Nov 07, 2024	BUY	$70.96 - $82.35 $7.1 Million - $8.23 Million	100,000 Added 100.0%	200,000 $16 Million
Q2 2024 Aug 12, 2024	BUY	$62.12 - $84.15 $1.24 Million - $1.68 Million	20,000 Added 25.0%	100,000 $7.17 Million
Q1 2024 May 13, 2024	SELL	$65.98 - $77.09 $14.5 Million - $17 Million	-220,000 Reduced 73.33%	80,000 $5.63 Million
Q4 2023 Feb 09, 2024	BUY	$52.83 - $78.22 $1.32 Million - $1.96 Million	25,000 Added 9.09%	300,000 $23.1 Million
Q3 2023 Nov 09, 2023	SELL	$67.52 - $89.42 $1.69 Million - $2.24 Million	-25,000 Reduced 8.33%	275,000 $18.7 Million
Q2 2023 Aug 16, 2023	BUY	$73.76 - $85.98 $22.1 Million - $25.8 Million	300,000 New	300,000 $24.5 Million

Others Institutions Holding TECH

# of Institutions

613

Shares Held

161M

Call Options Held

225K

Put Options Held

80.8K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.49B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Broadcrest Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Broadcrest Asset Management, LLC with notifications on news.

Account

Broadcrest Asset Management, LLC Bio Techne Corp Transaction History